Skip to main content
Have a personal or library account? Click to login
Evaluation of tumor angiogenesis in patients with non-small cell lung carcinoma Cover

Evaluation of tumor angiogenesis in patients with non-small cell lung carcinoma

ARS Medica Tomitana
Volume 21 (2015): Issue 2 (May 2015)
By: ,  ,  ,  ,  ,  ,   and    
Open Access
|Jul 2015
References

References

  1. 1. Parkin, D.M., Bray, F., Ferlay, J. & Pisani, P. (2005). Global cancer statistics, 2002. CA: Cancer J Clin. 55, 74-108
    Open DOISearch in Google Scholar
  2. 2. Dudek, A.Z. & Mahaseth, H. (2005). Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival. Cancer Invest. 23, 193 - 200
    Open DOISearch in Google Scholar
  3. 3. Bremnes, R.M., Camps, C. & Sirera, R. (2006). Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumors and blood. Lung Cancer. 51, 143-58
    Open DOISearch in Google Scholar
  4. 4. Tanaka, F., Otake, Y. & Yanagihara, K. et al. (2001). Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res. 7, 3410 - 3415
    Search in Google Scholar
  5. 5. Sun, S. & Schiller, J.H. (2007). Angiogenesis inhibitors in the treatment of lung cancer. Clinical Reviews in Oncology/Hematology. 62, 93-104
    Open DOISearch in Google Scholar
  6. 6. Folkman, J. (1992). The role of angiogenesis in tumor growth. Semin Cancer Biol. 3, 65-71
    Search in Google Scholar
  7. 7. Kerbel, RS. (2000). Tumor angiogenesis: past, present and the near future. Carcinogenesis. 21, 505-515
    Open DOISearch in Google Scholar
  8. 8. Macchiarini, P., Fontanini, G. & Hardin, M.J. et al. (1992). Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet. 340, 145-56
    Open DOISearch in Google Scholar
  9. 9. Traweek, S.T., Kandalaft, P.L., Mehta, P. & Battifora, H. (1991). The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am. J. Clin. Pathol. 96, 25-31
    Search in Google Scholar
  10. 10. Kuzu, I., Bicknell, R., Harris, A.L., Jones, M., Gatter, K.C. & Mason, D.Y. (1992). Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumors. J. Clin. Pathol. 45, 143-148
    Search in Google Scholar
  11. 11. Martin, L., Holcombe, C., Green, B., Leinster, S.J. & Winstanley, J. (1997). Is a histological section representative of whole tumor vascularity in breast cancer? Br. J. Cancer. 76, 40-43
    Search in Google Scholar
  12. 12. Weidner, N., Semple, J.P., Welch, W.R. & Folkman, J. (1992). Tumor angiogenesis and metastasis correlation in invasive breast cancer. N. Engl. J. Med. 324, 1-8
    Search in Google Scholar
  13. 13. De Jong, J.S., Van Diest, P.J. & Baak, J.P.A. (1995). Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab. Invest. 73, 992-996
    Search in Google Scholar
  14. 14. Vieira, S.C., Silva, B.B., Pinto, G.A., Vassallo, J., Moraes, N.G., Santana, J.O.I., Santos, L.G., Carvasan, G.A.F. & Zeferino, L.C. (2005). CD34 as a marker for evaluating angiogenesis in cervical cancer. Pathology - Research and practice. 201, 313-18
    Open DOISearch in Google Scholar
  15. 15. Barbareschi, M., Weidner, N. & Gasparini, G. (1995). Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. computer-aided image analysis system. Appl. Immunohistochem. 2, 75-84
    Search in Google Scholar
  16. 16. Vermeulen, P.B., Verhoeven, D., Fierens, H., Hubens, G., Goovaerts, G., Van Marck, E., De Bruijn, E.A., Van Oosterom, A.T. & Dirix, L.Y. (1995). Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br. J. Cancer. 71, 340-343
    Open DOISearch in Google Scholar
  17. 17. Meert, A.P, Paesmans, M. & Martin, B. et al. (2002). The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with metaanalysis. Br J Cancer. 87, 694-701
    Open DOISearch in Google Scholar
  18. 18. Johnson, D.H., Fehrenbacher, L. & Novotny, W.F. et al. (2004). Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 22, 2184-2191
    Open DOISearch in Google Scholar
  19. 19. Kadota, K., Huang, C., Liu, D., Ueno, M., Kushida, Y., Haba, R. & Yokomise, H. (2008). The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. European Journal of Cancer. 44, 1057-1067
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/arsm-2015-0025 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666
Journal RSS Feed
Language: English
Page range: 81 - 86
Published on: Jul 29, 2015
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
lung cancer,
adenocarcinoma,
angiogenesis
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2015 B.A. Suciu, T. Mezei, Zsuzsanna Pap, L. Denes, Ioana Hălmaciu, Z. Pavai, Klara Brînzaniuc, L. Azamfirei, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 21 (2015): Issue 2 (May 2015)
Previous article
Next article